Regional myocardial ischemia in hypertrophic cardiomyopathy: Impact of myectomy

Journal of Thoracic and Cardiovascular Surgery

Volumn 128, Issue 2, 2004, Pages 163-169

  Jörg Ciopor, Manuela ^a   Namdar, Mehdi ^a   Turina, Jurai ^a   Jenni, Rolf ^a   Schwitter, Jürg ^a   Turina, Marko ^a   Hess, Otto M ^b   Kaufmann, Philipp A ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Swiss Heart Center   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

17; 22; 23

Indexed keywords

AMMONIA; DIPYRIDAMOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; EVALUATION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; HUMAN EXPERIMENT; HYPEREMIA; HYPERTROPHIC CARDIOMYOPATHY; MUSCLE RESECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORAX PAIN;

CARDIOMYOPATHY, HYPERTROPHIC; CORONARY CIRCULATION; HUMANS; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

EID: 3242753648     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.11.003     Document Type: Article

References (26)

1. Maron B.J., Fananzapir L. Sudden cardiac death in hypertrophic cardiomyopathy. Circulation. 85:(Suppl):1992;157-163
2. Maron B.J., Epstein S.E., Roberts W.C. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol. 43:1979;1086-1102
3. Pasternac A., Noble J., Streulens Y., Elie R., Henschke C., Bourassa M.G. Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries. Circulation. 65:1982;778-789
4. Kaufmann P., Vassalli G., Lupi W.S., Jenni R., Hess O.M. Coronary artery dimensions in primary and secondary left ventricular hypertrophy. J Am Coll Cardiol. 28:1996;745-750
5. Vassalli G., Kaufmann P., Villari B., Jakob M., Boj H., Kiowski W., et al. Reduced epicardial coronary vasodilator capacity in patients with left ventricular hypertrophy. Circulation. 91:1995;2916-2923
6. Camici P., Chiriatti G., Lorenzoni R., Bellina R.C., Gistri R., Italiani G., et al. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol. 17:1991;879-886
7. Krams R., Kofflard M.J.M., Duncker D.J., Von Birgelen C., Carlier S., Kliffen M., et al. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation. 97:1998;230-233
8. Cleland W.P. The surgical management of obstructive cardiomyopathy. J Cardiovasc Surg (Torino). 4:1963;4889-4891
9. Seiler C., Hess O.M., Schoenbeck M., Turina J., Jenni R., Turina M., et al. Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy a retrospective study (see comments). J Am Coll Cardiol. 17:1991;634-642
10. Maron M.S., Olivotto I., Batocchi S., Casey S.A., Lesser J.R., Losi M.A., et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 348:2003;295-303
11. Diamond G., Forrester J. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med. 300:1979;1350-1358
12. Muzik O., Beanlands R.S., Hutchins G.D., Mangner T.J., Nguyen N., Schwaiger M. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med. 34:1993;83-91
13. Hutchins G.D., Caraher J.M., Raylman R.R. A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. J Nucl Med. 33:1992;1243-1250
14. Kaufmann P.A., Gnecchi-Ruscone T., Schafers K.P., Luscher T.F., Camici P.G. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol. 36:2000;103-109
15. Grover-McKay M., Schwaiger M., Krivokapich J., Perloff J.K., Phelps M.E., Schelbert H.R. Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy (see comments). J Am Coll Cardiol. 13:1989;317-324
16. Hutchins G.D., Schwaiger M. Quantitative evaluation of myocardial perfusion. Schwaiger M. Cardiac emission tomography. 1996;98-118 Kluwer Academic Publisher, Boston/Dordrecht/London
17. de Silva R., Camici P.G. Role of positron emission tomography in the investigation of human coronary circulatory function. Cardiovasc Res. 28:1994;1595-1612
18. Zeiher A.M., Drexler H., Wollschläger H., Saurbier B., Just H. Coronary vasomotion in response to sympathetic stimulation in humans importance of the functional integrity of the endothelium. J Am Coll Cardiol. 14:1989;1181-1190
19. Schafers M., Dutka D., Rhodes C.G., Lammertsma A.A., Hermansen F., Schober O., et al. Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ Res. 82:1998;57-62
20. Camici P.G., Cecchi R.G., Montereggi A., Salvadori P.A., Dolara A., L'Abbate A. Dipyridamole-induced subendocardial underperfusion in hypertrophic cardiomyopathy assessed by positron-emission tomography. Coron Artery Dis. 2:1991;837-841
21. Cannon R.O. III, Dilsizian V., O'Gara P.T., Udelson J.E., Schenke W.H., Quyyumi A., et al. Myocardial, metabolic, hemodynamic, and eletrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation. 83:1991;1660-1667
22. Czernin J., Muller P., Chan S., Brunken R.C., Porenta G., Krivokapich J., et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation. 88:1993;62-69
23. Uren N.G., Camici P.G., Melin J.A., Bol A., de Bruyne B., Radvan J., et al. Effect of aging on myocardial perfusion reserve. J Nucl Med. 36:1995;2032-2036
24. Hess O.M., Murakami T., Krayenbuehl H.P. Does verapamil improve left ventricular relaxation in patients with myocardial hypertrophy? Circulation. 74:1986;530-543
25. Choudhury L., Elliott P., Rimoldi O., Ryan M., Lammertsma A.A., Boyd H., et al. Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment. Am J Cardiol. 74:1994;363-368
26. Gistri R., Cecchi F., Choudhury L., Montereggi A., Sorace O., Salvadori P.A., et al. Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy. Am J Cardiol. 74:1994;363-368